Navigation Links
Gauze-based NPWT Capable of Achieving Same Treatment Goals as Foam-based NPWT
Date:10/24/2009

ST. PETERSBURG, Fla., Oct. 23 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), highlighted the results of a multi-center study which demonstrates that gauze-based Negative Pressure Wound Therapy (NPWT) achieves many of the common treatment goals defined for foam-based NPWT systems. These goals include a reduction in wound dimension, exudate, and improvement in granulation tissue. A second poster highlighting a sub-set of patients in the same study found that skin graft take was dramatically enhanced and care facilitated by gauze-based NPWT.

The results of this study were presented in a poster session today at the 24th Annual Clinical Symposium on Advances in Skin and Wound Care in San Antonio, Texas.

The prospective, multi-center clinical evaluation assessed 131 non-grafted patients at 21 centers in the United States, Canada, United Kingdom, Saudi Arabia and the United Arab Emirates. Its results included:

  • Wound dimensions were all significantly reduced during gauze-based NPWT (p<0.001). A weekly percentage reduction in wound area, depth and volume of 8.3%, 15.8% and 20.5% respectively was observed;
  • There was a significant reduction (p<0.001) in wound exudate levels from baseline to treatment discontinuation;
  • There was also a significant increase (p=0.007) in the percentage area of the wound bed composed of red granulation tissue over the course of gauze-based NPWT.

"Gauze-based NPWT can be used to address many of the treatment goals commonly defined at the onset of applying other NPWT systems," said Dr. Raymond Dunn, Chairman of Plastic Surgery, University of Massachusetts and lead author of the poster. "Clinicians in this study found the gauze-based negative pressu
'/>"/>

SOURCE Smith & Nephew Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
3. CRESTOR(R) Reduced CV Risk in Patients Achieving Low LDL and hsCRP Targets in New JUPITER Analysis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... to Millennium Research Group (MRG), the global authority ... minimally invasive spinal fusion market will expand at ... through 2014, reimbursement concerns in certain segments will ... had been forecast at almost 20%. ,, MRG,s ... 2010 report finds that the ...
(Date:12/16/2009)... Engineered Technologies (HDT), a leader in the development ... for the mechanical development of the Modular Prosthetic ... technology that will give patients improved, dexterous control ... sense of touch. ,, As part of ... Prosthetics 2009 (RP2009) project, the MPL overcomes the ...
(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 16 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that its president and chief ... present at the 28th Annual J.P. Morgan Healthcare Conference ... 9:30 a.m. PT/12:30 p.m. ET. ,, A live ... the investor relations page of the Company,s Web site ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 1Tribe Makes Payment of 24945 000 to Assist County With Emergency Services and Fire Protection 48489 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 1Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 3Lumbar Matrix 28TM 29 Scan From SpineMatrix 28R 29 Revolutionizes the Diagnosis of Low Back Pain 12567 1Lumbar Matrix 28TM 29 Scan From SpineMatrix 28R 29 Revolutionizes the Diagnosis of Low Back Pain 12567 2Lumbar Matrix 28TM 29 Scan From SpineMatrix 28R 29 Revolutionizes the Diagnosis of Low Back Pain 12567 3
... June 04, 2007 /PRNewswire/ -- GlaxoSmithKline today,announced ... pazopanib in,advanced or metastatic renal cell carcinoma ... These trials were presented at the,43rd Annual ... Oncology,(ASCO) in Chicago. The results observed in ...
... - Copernicus Therapeutics,Inc. announced today that a research ... by Dr. Muna Naash, Professor of Cell,Biology, demonstrated ... mouse model of retinitis pigmentosa (RP). These,findings were ... in Seattle, WA. Mutations in genes important in ...
Other Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA,Nanoparticles 2
(Date:12/16/2009)... CLEVELAND -- December 16, 2009 -- Every year ... are diagnosed, and 57,000 patients die of the disease, ... cancer among adults, after lung cancer. , As researchers ... colorectal cancer -- simultaneously generating thousands of studies producing ... professor and researcher of cancer and genetics at Case ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... Allscripts (Nasdaq: MDRX ) announced today that ... three and six months ended November 30, 2009 ... 11, 2010. Allscripts management will host a conference ... and other information at 8:30 AM Eastern Standard ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter earnings ...
(Date:12/16/2009)... Dec. 16 The most widely used human embryonic ... raises social justice questions that must be addressed to ... cell advances, according to a University of Michigan research ... kind, the U-M team analyzed 47 embryonic stem cell ... stem cell researchers. The scientists determined the genetic ancestry ...
(Date:12/16/2009)... HealthSciences Institute will sponsor a new learning ... organizations who serve individuals at risk of, ... health plan, medical home and other provider ... noncommercial webinars on topics, solutions and case ... care improvement. Each webinar will include a ...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Immucor Appoints New Board Director 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3
... of the treatment for prostrate cancer seem to cope better ... reported better psychological and social well being after the surgery ... their well being after surgery than men who did not ... is slated to come out in the July issue of ...
... manning the progress of osteoarthritis// of the hip, it helps ... space narrowing that is accompanied by severe pain and functional ... hip replacement operation in patients who may have suffered severe ... progression. ,The researchers had studied 1904 men and ...
... normal birth weight or were not breast-fed may be// at ... from the University at Buffalo who presented this finding at ... this is especially true for women in their pre-menopausal age. ... phase is the most important phase of life for the ...
... UK had said in the journal The Lancet that for ... a history of breast cancer in their families, MRI scanning ... who have a family history of breast cancer are predisposed ... screened for breast cancer from early adulthood. Screening young women ...
... A hospital in New zealand had fitted the first ptient ... ,The special device is designed to help patients with moderate ... for a heart transplant and its related side effects. These ... in walking short distances and do not get much help ...
... alcohol intakes than men, suggests a research report made public ... of Pittsburgh School of Medicine had said that drinking alcohol ... male counterparts. Women may be more at risk of liver ... the same amount of the drink. ,Researchers had ...
Other Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: